Fibroblast Growth Factor 2 Enhances Zika Virus Infection in Human Fetal Brain.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
13 09 2019
Historique:
received: 14 12 2018
accepted: 12 02 2019
pubmed: 26 2 2019
medline: 28 5 2020
entrez: 26 2 2019
Statut: ppublish

Résumé

Zika virus (ZIKV) is an emerging pathogen that can cause microcephaly and other neurological defects in developing fetuses. The cellular response to ZIKV in the fetal brain is not well understood. Here, we show that ZIKV infection of human fetal astrocytes (HFAs), the most abundant cell type in the brain, results in elevated expression and secretion of fibroblast growth factor 2 (FGF2). This cytokine was shown to enhance replication and spread of ZIKV in HFAs and human fetal brain explants. The proviral effect of FGF2 is likely mediated in part by suppression of the interferon response, which would represent a novel mechanism by which viruses antagonize host antiviral defenses. We posit that FGF2-enhanced virus replication in the fetal brain contributes to the neurodevelopmental disorders associated with in utero ZIKV infection. As such, targeting FGF2-dependent signaling should be explored further as a strategy to limit replication of ZIKV.

Identifiants

pubmed: 30799482
pii: 5319999
doi: 10.1093/infdis/jiz073
pmc: PMC6743838
doi:

Substances chimiques

Fibroblast Growth Factor 2 103107-01-3
Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1377-1387

Subventions

Organisme : CIHR
ID : PJT-148699
Pays : Canada
Organisme : CIHR
ID : ZV1-149782
Pays : Canada

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Cell Death Differ. 1999 May;6(5):463-70
pubmed: 10381633
J Biol Chem. 2003 Feb 21;278(8):6495-502
pubmed: 12482879
J Virol. 2005 Jul;79(13):8388-99
pubmed: 15956583
Mol Cell Biol. 2006 Apr;26(7):2758-71
pubmed: 16537918
Development. 2008 Dec;135(24):4015-24
pubmed: 19004858
Mucosal Immunol. 2008 Sep;1(5):372-81
pubmed: 19079201
Nat Protoc. 2009;4(2):256-69
pubmed: 19197269
Acta Neuropathol. 2010 Jan;119(1):7-35
pubmed: 20012068
J Virol. 2010 Sep;84(17):8721-31
pubmed: 20538858
PLoS One. 2010 Sep 21;5(9):e12856
pubmed: 20877724
Am J Hum Genet. 2011 Dec 9;89(6):713-30
pubmed: 22152675
J Med Virol. 2012 Sep;84(9):1501-5
pubmed: 22825831
PLoS One. 2012;7(8):e44252
pubmed: 22952941
J Virol. 2013 Jan;87(2):872-81
pubmed: 23115297
Oncogene. 2015 Jul 23;34(30):3985-93
pubmed: 25347735
Cancer Lett. 2015 Feb 28;357(2):575-81
pubmed: 25497010
Wiley Interdiscip Rev Dev Biol. 2015 May-Jun;4(3):215-66
pubmed: 25772309
Gut. 2016 Jun;65(6):1015-23
pubmed: 25800783
Nat Med. 2015 May;21(5):530-6
pubmed: 25894825
J Immunol. 2015 Nov 15;195(10):4943-52
pubmed: 26466960
Med Microbiol Immunol. 2016 Jun;205(3):269-73
pubmed: 26702627
Ultrasound Obstet Gynecol. 2016 Jan;47(1):6-7
pubmed: 26731034
N Engl J Med. 2016 Mar 10;374(10):951-8
pubmed: 26862926
N Engl J Med. 2016 Dec 15;375(24):2321-2334
pubmed: 26943629
Cell Stem Cell. 2016 May 5;18(5):587-90
pubmed: 26952870
N Engl J Med. 2016 Jun 2;374(22):2142-51
pubmed: 27028667
Clin Microbiol Rev. 2016 Jul;29(3):487-524
pubmed: 27029595
Genes Dev. 2016 Apr 1;30(7):751-71
pubmed: 27036966
PLoS Negl Trop Dis. 2016 Apr 19;10(4):e0004682
pubmed: 27093158
Cancer Treat Rev. 2016 May;46:51-62
pubmed: 27109926
Cell. 2016 May 19;165(5):1238-1254
pubmed: 27118425
Gene. 2016 Sep 1;589(1):1-11
pubmed: 27155521
Lancet. 2016 Aug 27;388(10047):898-904
pubmed: 27372395
PLoS One. 2016 Aug 10;11(8):e0160529
pubmed: 27508303
Nat Med. 2016 Nov;22(11):1256-1259
pubmed: 27618651
EBioMedicine. 2016 Oct;12:161-169
pubmed: 27688094
JAMA Neurol. 2016 Dec 1;73(12):1407-1416
pubmed: 27695855
mSphere. 2016 Sep 28;1(5):
pubmed: 27704051
J Clin Oncol. 2017 Jan 10;35(2):157-165
pubmed: 27870574
PLoS Negl Trop Dis. 2017 Jan 9;11(1):e0005296
pubmed: 28068342
PLoS Pathog. 2017 Mar 9;13(3):e1006258
pubmed: 28278235
J Infect Dis. 2017 Jul 15;216(2):172-181
pubmed: 28838147
J Clin Oncol. 2018 Jan 20;36(3):276-282
pubmed: 29182496
Virology. 2018 Mar;516:147-157
pubmed: 29358114
J Neuroinflammation. 2018 Mar 15;15(1):80
pubmed: 29544502
Sci Rep. 2018 Apr 3;8(1):5477
pubmed: 29615760
Virology. 2018 Sep;522:199-208
pubmed: 30036788
Viruses. 2018 Nov 17;10(11):
pubmed: 30453621

Auteurs

Daniel Limonta (D)

Department of Cell Biology, University of Alberta, Edmonton, Canada.

Juan Jovel (J)

Department of Medicine, University of Alberta, Edmonton, Canada.

Anil Kumar (A)

Department of Cell Biology, University of Alberta, Edmonton, Canada.

Julia Lu (J)

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.

Shangmei Hou (S)

Department of Cell Biology, University of Alberta, Edmonton, Canada.

Adriana M Airo (AM)

Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.

Joaquin Lopez-Orozco (J)

Department of Cell Biology, University of Alberta, Edmonton, Canada.

Cheung Pang Wong (CP)

Department of Cell Biology, University of Alberta, Edmonton, Canada.

Leina Saito (L)

Department of Medicine, University of Alberta, Edmonton, Canada.

William Branton (W)

Department of Medicine, University of Alberta, Edmonton, Canada.

Gane Ka-Shu Wong (GK)

Department of Medicine, University of Alberta, Edmonton, Canada.
Department of Biological Sciences, University of Alberta, Edmonton, Canada.
BGI Group, Shenzhen, China.

Andrew Mason (A)

Department of Medicine, University of Alberta, Edmonton, Canada.
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.
Women and Children's Health Research Institute, University of Alberta, Edmonton, Canada.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.

Christopher Power (C)

Department of Medicine, University of Alberta, Edmonton, Canada.
Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Canada.
Women and Children's Health Research Institute, University of Alberta, Edmonton, Canada.

Tom C Hobman (TC)

Department of Cell Biology, University of Alberta, Edmonton, Canada.
Department of Medicine, University of Alberta, Edmonton, Canada.
Women and Children's Health Research Institute, University of Alberta, Edmonton, Canada.
Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH